The Latest Cardiac and Vascular News
Initial program aims to reduce congestive heart failure readmissions with potential savings of about $1M ATLANTA, Sept. 18, 2019 (GLOBE NEWSWIRE) — Jvion, a leader in AI-enabled prescriptive analytics for preventable harm, today announced a partnership with Novant Health as part of the newly launched Novant Health Institute of Innovation & Artificial Intelligence. Working […]
SAN DIEGO, Sept. 17, 2019 /PRNewswire/ — Abcentra, a clinical-stage bio-pharmaceutical company that addresses unmet needs in inflammation, today announced its contribution to a 2019 study published in the American Heart Association Journals. The study found that, in those with high-cholesterol and major histocompatibility complex class II (MHCII) cells, treating atherosclerosis with immunotherapy […]
– World’s smallest pediatric treatments pioneered by Abbott address critical needs for the most vulnerable patients: babies and children born with common congenital heart defects – Includes pediatric mechanical heart valve and first minimally invasive device to treat premature babies and newborns born with an opening in their heart […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq: ELGX) (the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today the grant of inducement equity awards to two newly hired employees (together, the “Awardees”). The awards were approved by the Company’s Compensation Committee, which is comprised of independent directors, on […]
SALT LAKE CITY–(BUSINESS WIRE)–Foldax, Inc. today announced its first-in-human use of the Tria heart valve under its FDA Early Feasibility Study (EFS) for the treatment of aortic valve disease. Clinicians at Beaumont Hospital, Royal Oak, in Michigan, implanted this innovative flexible polymer heart valve, which has the potential to address […]
ST. LOUIS, Mo., Sept. 16, 2019 (GLOBE NEWSWIRE) — Stereotaxis (NYSE American: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that Kimberly Peery has been appointed Stereotaxis Chief Financial Officer, effective October 1, 2019. Martin Stammer, who has served as Chief Financial […]
WINNIPEG, Sept. 17, 2019 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the launch of the ReDSTM PRO (“ReDSTM PRO”) system, the next generation of lung fluid management technology for heart failure. The debut of the new system took place at the recent Heart […]
First-of-kind solution now in clinical use at North Memorial Health LEXINGTON, Mass., Sept. 17, 2019 /PRNewswire/ — FUJIFILM Medical Systems U.S.A., Inc., a leading provider of Enterprise Imaging and Medical Informatics solutions, has just launched Synapse Cardiology PACS 5.6.1, the company’s next-generation server-side rendering solution to help streamline image review and reporting across cardiovascular modalities. This […]
SAN DIEGO, Sept. 17, 2019 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has named AnaBios the recipient of a grant to further develop its unique drug discovery platform utilizing muscle cells from the human heart (cardiomyocytes). Funds from the grant will be used to develop a preclinical biomarker to identify the […]
Merger strengthens European service and expands cardiovascular customization capabilities VICTORIA and MARSEILLE, France, Sept. 17, 2019 /PRNewswire/ — ViVitro Labs, the industry-leading provider of cardiovascular device test equipment and related consulting services, announces the acquisition of ProtomedLabs SASU, an ISO 17025 accredited medical device testing laboratory based in Marseille France. The companies will merge operations and form […]
